Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acne Vulgaris and Rosacea Acne Vulgaris Acneiform Eruptions Rosacea Sebaceous Gland Diseases Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bispebjerg Hospital

Copenhagen NV, 2400, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Inflammatory acne and rosacea
Skin types I-IV

Exclusion criteria

Patients younger than 18 years
Skin types V and VI
Topical and systemic conventional acne treatments

Treatment and study plan

Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)

Device

Long-pulsed dye laser

Device

Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Device

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Registry information

Important dates

Study start: 2006
Study completion: 2007
First posted: Jun 6, 2007
Registry last updated: Jun 3, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed